KEBOMED A/S: Financial statements 2020
CVR: 28490704
Source: annual report 2020, Danish Business Authority
01/07/2019 – 30/06/2020
KEBOMED A/S (CVR 28490704) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 38,994,342 and a net result of DKK 9,022,239 compared with DKK 8,254,157 the year before. That is an increase of 3.3% compared with the year before. Equity in the 2020 report amounted to DKK 18,337,787. The solvency ratio was 47.4%.
- Gross Profit
- DKK 38,994,342
- Profit/Loss
- DKK 9,022,239
- Equity
- DKK 18,337,787
- Total Assets
- DKK 38,682,313
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 39M | 9M | 18.3M | - |
| 2019 | - | 37.8M | 8.3M | 9.3M | - |
| 2018 | - | 41.2M | 11.6M | 12.6M | - |
| 2017 | - | 40.9M | 6.8M | 16.8M | - |
| 2016 | - | 37.7M | 9M | 10M | - |
Official annual report
How creditworthy is KEBOMED A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout KEBOMED A/S
KEBOMED A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2005. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named KEBO MED A/S. The management consists of Henrik Schjødt. The board consists of Niels Søren Frederik Kornerup (chair), Henrik Schjødt and Søren Dalmark Kornerup. The company is owned by Kebomed Europe Holding AG. The company has 23 employees (2026). In 2026, the company reported a gross profit of DKK 52,977,983 and a net result of DKK 13,110,236 compared with DKK 9,827,524 the year before. Equity in the 2026 report amounted to DKK 36,352,192.